Traitement de seconde ligne dans le mésothéliome pleural malin. Étude rétrospective française (2005-2006)

This experience indicates the feasibility of administering SLC in patients with MPM who are healthy at the time of the progression of the disease. The optimal treatment has not been defined to date and prospective trials are needed.